Advertisement
Research Article| Volume 16, ISSUE 3, P527-550, September 1996

Biosafety in the Clinical Mycobacteriology Laboratory

DOI:https://doi.org/10.1016/S0272-2712(18)30254-3
Biosafety in the Clinical Mycobacteriology Laboratory
Previous ArticleThe Mycobacteriology Laboratory: Past, Present, and Future
Next ArticlePrimary Processing of Specimens and Isolation and Cultivation of Mycobacteria
      This paper is only available as a PDF. To read, Please Download here.
      This article presents an expanded agent summary statement for laboratorians working with Mycobacterium tuberculosis. It focuses on reducing the serious risk of infection in clinical laboratories that process specimens from tuberculosis patients or that work with purified cultures of tubercle bacilli. Administrative and engineering controls, practices and procedures, and personal protective equipment are discussed. Guidelines for packaging specimens for transfer to another laboratory also are presented.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Balasubramanian V.
        • Wiegeshaus E.H.
        • Taylor B.T.
        • et al.
        Pathogenesis of tuberculosis: Pathway to apical localization.
        Tuber Lung Dis. 1994; 75: 168
        • Centers for Disease Control
        Recommendations of the Immunization Practices Advisory Committee (ACIP). Use of BCG vaccines in the control of tuberculosis: A joint statement by the ACIP and the Advisory Committee for Elimination of Tuberculosis.
        MMWR Morb Mortal Wkly Rep. 1988; 37: 663
        • Centers for Disease Control
        Update: Universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings.
        MMWR Morb Mortal Wkly Rep. 1988; 37: 377

      4. Centers for Disease Control: Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, MMWR Morb Mortal Wkly Rep 43(no. RR-13), 1994, pp 1-132

        • Centers for Disease Control
        Essential components of a tuberculosis prevention and control program.
        MMWR Morb Mortal Wkly Rep. 1995; 44: RR-11

      6. Centers for Disease Control: Working safely with Mycobacterium tuberculosis complex species in clinical, research and public health laboratories. MMWR Morb Mortal Wkly Rep, in press

      7. Centers for Disease Control/National Institutes of Health: Biosafety in Microbiological and Biomedical Laboratories, ed 3. Atlanta, US Dept of Health and Human Services, Public Health Service, 1993. DHHS publication (CDQ93-8395)

      8. Centers for Disease Control/National Institutes of Health: Primary Containment for Biohazards: Selection, Installation and Use of Biological Safety Cabinets, Dept of Health and Human Services, 1995

        • Collins C.H.
        Laboratory-Acquired Infections. Butterworths, London1983
        • Gershon R.M.
        • Zirkin B.F.
        Behavioral factors in safety training.
        in: Fleming DL Richardson JH Tubs JJ Laboratory Safety: Principles and Practices. ed 2. DC; American Society for Microbiology, Washington1994: 269
        • Gilchrist M.J.R.
        Biosafety precautions for airborne pathogens.
        in: Fleming DO Richardson JH Tulis JJ Laboratory Safety: Principles and Practices. ed 2. American Society for Microbiology, Washington, DC1995: 67

      12. Gilchrist MJR, Hindler J, Fleming DO: Laboratory safety management update: Aerosol borne microorganisms. In Isenberg HD (ed): Clinical Microbiology Procedures Handbook. Washington, DC, American Society for Microbiology, 1994 [supplement 1:1995]

        • Grist N.R.
        Hepatitis and other infections in clinical labortatory staff, 1979.
        J Clin Pathol. 1981; 34: 655
        • Grist N.R.
        • Emslie J.A.N.
        Association of clinical pathologists’ surveys of infection in British clinical laboratories, 1970-1989.
        J Clin Pathol. 1994; 47: 391-394
        • Good R.C.
        • Snider D.E.
        Isolation of non-tuberculosis mycobacteria in the U.S.
        J Infect Dis. 1982; 146: 829

      16. International Airline Transportation Association (IATA): Dangerous Goods Regulations, 1995

        • Jacobson J.T.
        • Orlob R.B.
        • Clayton J.L.
        Infections acquired in clinical laboratories in Utah.
        J Clin Microbiol. 1985; 21: 486

      18. Kubica GP, Dye WE: Laboratory Methods for Clinical and Public Health Mycobacteriology. Washington, DC, US Department of Health, Education, and Welfare, US Government Printing Office, Public Health Service publication 1547, 1985

        • Miller C.D.
        • Songer J.R.
        • Sullivan J.F.
        A twenty-five year review of laboratory-acquired human infections at the National Animal Disease Center.
        Am Ind Hyg Assoc J. 1987; 48: 271
        • Muller H.E.
        Laboratory-acquired mycobacterial infection.
        Lancet. 1988; 2: 331
        • Oliver J.
        • Reusser T.R.
        Rapid method for the concentration of tubercle bacilli.
        Am Rev Tuberc. 1942; 45: 450
        • Reid D.D.
        Incidence of tuberculosis among workers in medical laboratories.
        Br Med J. 1957; 2: 10
        • Richmond J.Y.
        Safe practices and procedures for working with human specimens in biomedical research laboratories.
        J Clin Immunol. 1988; 11: 115
        • Richmond J.Y.
        Developing a response to medical waste issues.
        ASM News. 1990; 56: 420
        • Riley R.L.
        Aerial dissemination of pulmonary tuberculosis.
        Am Rev Tuberc. 1957; 76: 931
        • Riley R.L.
        Airborne pulmonary tuberculosis.
        Bacteriol Rev. 1961; 25: 243
        • Saint-Paul M.
        • Delpace Y.
        • Tufel C.
        • et al.
        Tuberculoses professionelles dans les laboratories de bacteriologie.
        Arch Mai Prof Med Trav. 1972; 33: 305
        • Sewell D.L.
        Laboratory-associated infections and biosafety.
        Clin Microbiol Rev. 1995; 8: 389
        • Shinnick T.M.
        • Good R.C.
        Mycobacterial taxonomy.
        Eur J Clin Microbiol Infect Dis. 1994; 13: 884
        • Small P.M.
        • Schecter G.F.
        • Goodman P.C.
        • et al.
        Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection.
        N Engl J Med. 1991; 324: 289
        • Smithwick R.W.
        • Stratigos C.B.
        Preparation of acid-fast microscopy smears for proficiency testing and quality control.
        J Clin Microbiol. 1978; 8: 110-111
        • Tenover F.C.
        • Crawford J.T.
        • Huebner R.E.
        • et al.
        The resurgence of tuberculosis: Is your laboratory ready?.
        J Clin Microbiol. 1993; 31: 767
        • US Department of Labor, Occupational Safety and Health Administration
        Occupational exposure to bloodborne pathogens: Final rule.
        Federal Register. 1991; 56: 64175-64182
        • US Department of Health and Human Services, Public Health Service
        Respiratory protective devices: Final rules and notice (42 CFR part 84).
        Federal Register. 1995; 60: 30335-30398

      35. US Department of Health and Human Services, Public Health Service: Foreign quarantine. Federal Register 42 CFR Part 71, 156, 1995

      36. US Department of Health and Human Services, Public Health Service: Interstate shipment of etiologic agents. Federal Register 42 CFR Part 72, 1995

      37. United States Postal Service: Mailability of etiologic agents. Codified in the domestic mail manual 124.38. Etiologic agent preparations, clinical specimens and biological products. Federal Register 39 CFR Part 111, 1996

      38. US Department of Transportation: Hazardous materials regulations (HMR). Federal Register 42 CFR Part 171-180, 1995

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)30254-3

      Copyright

      © 1996 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX